Claire Aldridge, assistant vice president of commercialization and business development at the University of Texas Southwestern, is achieving her goal of turning Dallas into a biotech hub. Aldridge helped launch Taysha Gene Therapies, she advises local public health authorities about COVID-19, from which she recovered, and she is the scientific advisor for Pegasus Park's Biotech Hub, where the UTSW Office for Technology Development's new center will encourage scientific collaboration.
White Paper: Complex Immuno-Oncology Trials. Immuno-oncology trials are increasing in prevalence and, for many reasons, are much more complex than standard clinical trials. Shipping, short timelines, strict conditions for maintaining sample integrity, and the need for detailed, international tracking, is complicated. Read more.
Glympse Bio co-founder Sangeeta Bhatia launched the Future Founders Initiative last year with former Massachusetts Institute of Technology president Susan Hockfield and biology professor emerita Nancy Hopkins to encourage more female faculty, postdocs and students at MIT and Harvard University to start biotechnology companies. The group has held a virtual boot camps and fireside chats, will facilitate networking and community building, and will offer a workshop series.
Tempus Senior Vice President for External Affairs Lauren Silvis is joining the Biden administration's COVID-19 response team and will focus on vaccines. Silvis served as chief of staff to former FDA Commissioner Scott Gottlieb, who wrote Silvis "helped promote key initiatives to improve medtech safety, modernize regulation of OTC drugs, fashioned efforts to advance AI medical devices and sequencing, will continue her public health contributions for USA."
Lindsay Lebahn, the former director of the Forge Young Professionals group, will lead outreach and communication as manager of Plug and Play's Topeka, Kan., business accelerator. Topeka is in the Kansas City Animal Health Corridor, and the local accelerator will focus on animal health and agricultural technology startups.
About 4,000 healthy women aged 18 and older who are 24 to 34 weeks pregnant will be randomly assigned to receive either two doses of Pfizer/BioNTech's COVID-19 vaccine or a placebo to be given 21 days apart. The global trial will assess the vaccine's safety, immunogenicity and tolerability, with each participant to be observed for an estimated seven to 10 months, dependent on whether they were given a placebo or vaccine.
Some academics say research universities can't achieve racial and gender diversity unless leaders weight mentoring, outreach and other efforts to promote diversity, equity and inclusion as heavily as grants won and papers published when considering promotions. Serving on task forces, mentoring students from underrepresented groups, and engaging in outreach take time away from research, and rewarding DEI efforts will incentivize others and lower the "minority tax," say people involved in the push.
Accenture is partnering with The Mom Project to hire 150 highly skilled moms for its Midwest division as part of its initiative to reach gender parity by 2025. The Mom Project is an online portal that connects professional women to job openings.
Students benefit from seeing role models who look like them, especially for Black students in STEM subjects, writes Jessie Woolley-Wilson, president and CEO of DreamBox Learning. Black STEM leaders who can be role models for students include Timnit Gebru, a researcher who focuses on ethical artificial intelligence, and Alexa Canady, the first African American female neurosurgeon in the US.
In celebration of International Women's Day, WIB is partnering with the UK-based BioIndustry Association (BIA) on March 10 to bring you the first transatlantic Women in Biotech event. Lisa Iadicicco, WIB Executive Director, will speak at the event, and WIB members are being offered £12 off the non-member ticket, the same discounted rate as BIA members. Email firstname.lastname@example.org for the discount code. Learn more or register.
Whether you're considering joining a board or you're already a board director, it's important to understand the ins and outs of Directors & Officers (D&O) insurance. Please join us for an in-depth look at D&O insurance and its implications for board directors with speakers Priya Cherian Huskins and Jane Njavro of Management Liability. Learn more or register.